Protein composition of plasminogen activator inhibitor type 1-derived endothelial microparticles

Shock

Volumn 29, Issue 4, 2008, Pages 504-511

  Sander, Tara L ^a   Ou, Jing Song ^a   Densmore, John C ^a   Kaul, Sushma ^a   Matus, Isaac ^b   Twigger, Simon ^b   Halligan, Brian ^b   Greene, Andrew S ^b   Pritchard Jr , Kirkwood A ^a   Oldham, Keith T ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

EMP; Endothelial cells; Microparticles; PAI 1; Proteome

Indexed keywords

LIPOCORTIN 5; PROHIBITIN; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UMBILICAL CORD; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; HUMANS; ISOELECTRIC FOCUSING; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 40949144531     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181454898     Document Type: Article

References (46)

1. Wolf P: The nature and significance of platelet products in human plasma. Br J Haematol 13:269-288, 1967.
2. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67:30-38, 2005.
3. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF: The platelet microparticle proteome. J Proteome Res 4:1516-1521, 2005.
4. Horstman LL, Ahn YS: Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999;30:111-142, 2005.
5. Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR, Ratajczak J, Emerson SG, Kowalska MA, Ratajczak MZ: Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98:3143-3149, 2001.
6. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, et al.: Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51:2840-2845, 2002.
7. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A: Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 46:2857-2866, 2002.
8. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, Hedman H, Freyssinet JM: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153:3245-3255, 1994.
9. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, Hivroz C: TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168:3235-3241, 2002.
10. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R: Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 288:H1004-H1009, 2005.
11. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R: Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 1:2561-2568, 2003.
12. Butikofer P, Kuypers FA, Xu CM, Chiu DT, Lubin B: Enrichment of two glycosyl-phosphatidylinositol-anchored proteins, acetylcholinesterase and decay accelerating factor, in vesicles released from human red blood cells. Blood 74:1481-1485, 1989.
13. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H: Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45:1622-1630, 2005.
14. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, Horstman LL, Ahn YS: Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56:1319-1324, 2001.
15. Essayagh S, Brisset AC, Terrisse AD, Dupouy D, Tellier L, Navarro C, Arnal JF, Sie P: Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists. Thromb Haemost 94:853-858, 2005.
16. Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, Pirillo A, Mussoni L, Tremoli E: Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 5:4443-4455, 2005.
17. Freyssinet JM: Cellular microparticles: what are they bad or good for? J Thromb Haemost 1:1655-1662, 2003.
18. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 264:17049-17057, 1989.
19. Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, Binder BR, Leitinger N: Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 22:101-107, 2002.
20. Gasser O, Hess C, Miot S, Deon C, Sanchez JC, Schifferli JA: Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 285:243-257, 2003.
21. Klinkner DB, Densmore JC, Kaul S, Noll L, Lim HJ, Weihrauch D, Pritchard KA Jr, Oldham KT, Sander TL: Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function. Shock 25:575-580, 2006.
22. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V: Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160:673-680, 2002.
23. Rajagopalan S, Somers EC, Brook RD, Kehrer C, Pfenninger D, Lewis E, Chakrabarti A, Richardson BC, Shelden E, McCune WJ, et al.: Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 103:3677-3683, 2004.
24. Morel O, Jesel L, Freyssinet JM, Toti F: Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosis. Thromb J 3:15, 2005.
25. Clancy RM: Circulating endothelial cells and vascular injury in systemic lupus erythematosus. Curr Rheumatol Rep 2:39-43, 2000.
26. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16:3381-3388, 2005.
27. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS: Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286:H1910-H1915, 2004.
28. Brogan PA, Shah V, Brachet C, Harnden A, Mant D, Klein N, Dillon MJ: Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 50:927-936, 2004.
29. Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD: Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 8:79-88, 2006.
30. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP: Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102:2678-2683, 2003.
31. Densmore JC, Signorino PR, Ou J, Hatoum OA, Rowe JJ, Shi Y, Kaul S, Jones DW, Sabina RE, Pritchard KA Jr, et al.: Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock 26:464-471, 2006.
32. Mezentsev A, Merks RM, O'Riordan E, Chen J, Mendelev N, Goligorsky MS, Brodsky SV: Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 289:H1106-H1114, 2005.
33. Agirbasli M: Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 59:102-106, 2005.
34. Nicholl SM, Roztocil E, Davies MG: Plasminogen activator system and vascular disease. Curr Vasc Pharmacol 4:101-116, 2006.
35. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS: Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 106:2372-2378, 2002.
36. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 19:837-844, 1998.
37. Rabilloud T, Adessi C, Giraudel A, Lunardi J: Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 18:307-316, 1997.
38. Wilkins MR, Gasteiger E, Sanchez JC, Bairoch A, Hochstrasser DF: Two-dimensional gel electrophoresis for proteome projects: the effects of protein hydrophobicity and copy number. Electrophoresis 19:1501-1505, 1998.
39. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037-1053, 2000.
40. Jin M, Drwal G, Bourgeois T, Saltz J, Wu HM: Distinct proteome features of plasma microparticles. Proteomics 5:1940-1952, 2005.
41. Santoni V, Molloy M, Rabilloud T: Membrane proteins and proteomics: un amour impossible? Electrophoresis 21:1054-1070, 2000.
42. Mayr U, Mayr M, Yin X, Begum S, Tarelli E, Wait R, Xu Q: Proteomic dataset of mouse aortic smooth muscle cells. Proteomics 5:4546-4557, 2005.
43. Lomax J: Get ready to GO! A biologist's guide to the Gene Ontology. Brief Bioinform 6:298-304, 2005.
44. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res 59:277-287, 2003.
45. Hirschberg D, Tryggvason S, Gustafsson M, Bergman T, Swedenborg J, Hedin U, Jornvall H: Identification of endothelial proteins by MALDI-MS using a compact disc microfluidic system. Protein J 23:263-271, 2004.
46. Graven KK, Molvar C, Roncarati JS, Klahn BD, Lowrey S, Farber HW: Identification of protein disulfide isomerase as an endothelial hypoxic stress protein. Am J Physiol Lung Cell Mol Physiol 282:L996-L1003, 2002.